0001493152-23-021476.txt : 20230615
0001493152-23-021476.hdr.sgml : 20230615
20230615171108
ACCESSION NUMBER: 0001493152-23-021476
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230504
FILED AS OF DATE: 20230615
DATE AS OF CHANGE: 20230615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jafri Hasan
CENTRAL INDEX KEY: 0001815352
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38630
FILM NUMBER: 231018378
MAIL ADDRESS:
STREET 1: 5941 OPTICAL COURT
CITY: SAN JOSE
STATE: CA
ZIP: 95138
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aridis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001614067
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320074500
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 983 UNIVERSITY AVENUE, BLDG. B
CITY: LOS GATOS
STATE: CA
ZIP: 95032
BUSINESS PHONE: (408) 385-1742
MAIL ADDRESS:
STREET 1: 983 UNIVERSITY AVENUE, BLDG. B
CITY: LOS GATOS
STATE: CA
ZIP: 95032
4
1
ownership.xml
X0407
4
2023-05-04
0
0001614067
Aridis Pharmaceuticals, Inc.
ARDS
0001815352
Jafri Hasan
C/O ARIDIS PHARMACEUTICALS, INC.
983 UNIVERSITY AVENUE, BLDG. B
LOS GATOS,
CA
95032
0
1
0
0
Chief Medical Officer
0
Common Stock
2023-06-05
4
M
0
10000
A
15100
D
Stock Options
0.16
2023-05-04
4
A
0
25000
0
A
2033-05-04
Common Stock
25000
155000
D
Restricted Stock Units
2023-06-05
4
M
0
10000
D
Common Stock
10000
10000
D
50% of the options vest on the three month anniversary of the date of grant and the remainder vest on the six month anniversary of the date of grant.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
10,000 shares of Common Stock vested on June 5, 2023 and 10,000 will vest on 12/5/2023. In the event that the Reporting Person's employment is terminated without cause by the Issuer, the RSUs will immediately vest.
/s/ Hasan Jafri
2023-06-15